HR5609-118

Introduced

To prohibit the use of Federal funds for security protection for the former Director of the National Institute of Allergy and Infectious Diseases who served between January 1984 and December 2022.

118th Congress Introduced Sep 20, 2023

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

This bill, To prohibit the use of Federal funds for security protection for the former Director of the National Institute of Allergy and Infectious Diseases who served between January 1984 and December 2022., changes federal law or congressional policy affecting federal agencies and legislative administrators. The main policy domain is Government Operations.

Who Benefits and How

federal agencies and legislative administrators may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.

Who Bears the Burden and How

federal implementing agencies may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.

Key Provisions

  • Section H869337FB4E24485383B833F0C2060EDB: 1. No Federal funds for security protection for the former Director of the National Institute of Allergy and Infectious Diseases who served between January...

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

This bill, To prohibit the use of Federal funds for security protection for the former Director of the National Institute of Allergy and Infectious Diseases who served between January 1984 and December 2022., changes federal law or congressional policy affecting federal agencies and legislative administrators.

Key Policy Areas

Government Operations

Primary Purpose

This bill, To prohibit the use of Federal funds for security protection for the former Director of the National Institute of Allergy and Infectious Diseases who served between January 1984 and December 2022., changes federal law or congressional policy affecting federal agencies and legislative administrators.

Policy Domains

Government Operations

Whole bill

Identified Gains
  • federal agencies and legislative administrators
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
federal agencies and legislative administrators:
Identified Costs
  • federal implementing agencies
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
federal implementing agencies:

Legislative Progress

Introduced
Introduced Committee Passed
Sep 20, 2023

Mr. Strong (for himself, Mr. Rogers of Alabama, Mr. Collins, …

Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Government Operations
Actor Mappings
"federal_implementing_agencies"
→ Federal agencies assigned duties by the bill

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology